Research Funding Opportunities
Could your research help accelerate the development of vaccines, drugs and diagnostics for COVID-19?
Research Opportunities to Impact COVID-19
Information about funding opportunities related to the novel coronavirus (COVID-19) will be added to this page as they become available.
Deadline |
Title |
Funding Agency |
More Information |
|---|---|---|---|
| Open Submissions | Up to $20,000 for single or multi-PIs for early stage translational projects. | IALS Midigrants | In response to the unprecedented COVID-19 pandemic, applications received related to resources for COVID-19 related projects shall be reviewed on a rolling basis by the Center Leadership Teams for quicker turnaround time. |
| Immediate Open Submissions | $10.6M in Grants for MA Manufacturers Pivoting to PPE | Mass. Manufacturing Emergency Response Team (M-ERT) | This funding is for manufacturers and contributing companies within Massachusetts to increase their in state production of PPE. Other applicants will be considered if they may contribute to the production of equipment listed above. |
| Rolling due dates | Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing |
NIH POCTRN-Rapid Acceleration of Diagnostics (RADx) |
NIBIB is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution. |
| Rolling due dates | COVID-19 Funding and Funding Opportunities | NIH | Leveraging resident expertise, getting additional funding to those researchers who are already working with other organisms, models, or tools so that they can quickly shift focus to the novel coronavirus. |
| Updated daily | Coronavirus Funding Monitor | Frontiers | A curated list of open funding calls and other support for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research. |
| Rolling-every two weeks | CIRM Special Call for COVID Projects | California Institute for Regenerative Medicine (CIRM) | Special announcement to support promising discovery, preclinical and clinical trialstageprojects that could quickly advance treatments to COVID-19 patients in need. |
| Updated daily | Regarding COVID-19/Coronavirus Situation | GrantForward | A list of grants ranging from small scale foundation to large-scale federal and targeting a range of applicants from the research community to commercial organizations. |
| July 10, 2021 | Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need | NIH | Projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. |
| March 25, 2021 | Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | National Institute of Allergy and Infectious Diseases (NIAID) | Projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. |
| February 06, 2021 | Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | National Institute of General Medical Sciences (NIGMS) | The urgent public health need to better understand SARS-CoV-2, particularly to improve the predictive quality of existing models of spread, diagnostics for measurement of transmission, susceptibility and recovery, and development of therapeutic interventions. |
| Open Submissions | SBIR/STTR Phase I Proposals Addressing COVID-19 | NSF | US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. |
| Immediate | Bill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response | Gates Foundation | $20 million to accelerate the detection, isolation and treatment of people diagnosed with the virus with the goal of interrupting transmission and containing the disease. $60 million to accelerate the discovery, development and testing of vaccines, treatments and diagnostics for 2019-nCoV. |
| COVID-19 Broad Agency Announcement | CDC | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | |
| April 01, 2021 | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (NOT-OD-20-097) | NIH | Supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health. |
| May 04, 2021 | Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (NOT-ES-20-020) | NIH-National Institute of Environmental Health Sciences (NIEHS) | Particular interests in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies.
|
| Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 | NSF | ||
| Dear Colleague Letter Request for SBIR/STTR Phase I Proposals Addressing COVID-19 (NSF 20-065) | |||
| Coronavirus Disease 2019 (COVID-19) Dear Colleague Letter (PDF) | Department of Energy | ||
| 2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities | Public Health Emergency | ||
| COVID-19 Open Research Dataset (CORD-19) | Allen Institute for AI |
